T
ATHE

TCWP’s Alterity Therapeutics ATHE Stock Holding History

TCWP’s Portfolio ATHE Stock Details ATHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-775
Closed -$6K – 373
2022
Q1 		$6K Buy
+775
New +$6.44K ﹤0.01% 1007

Other funds holding ATHE

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
PCA
Providence Capital Advisors Charlotte, North Carolina $613M AUM 17.83% 1-Year Est. Return

TCWP's ATHE Position: Q2 2022 in Review

TCWP sold out of Alterity Therapeutics (ATHE) in Q2 2022, closing a stake of 775 shares — an estimated $6K sold.

TCWP first reported a position in ATHE in Q1 2022 and held it in 1 quarter. The position peaked at $6K in Q1 2022. 10 funds tracked by Wall St. Rank hold ATHE as of Q2 2022.

  • TCWP reported no remaining Alterity Therapeutics position as of Q2 2022 after selling out during the quarter.
  • TCWP sold 775 Alterity Therapeutics shares in Q2 2022, an estimated $6K.
  • TCWP first reported a position in Alterity Therapeutics in Q1 2022 and held it in 1 quarter.
  • TCWP's Alterity Therapeutics position peaked at $6K in Q1 2022.
  • 10 funds tracked by Wall St. Rank held Alterity Therapeutics as of Q2 2022.

Based on TCWP's 13F filing for Q2 2022, filed 15 Aug 2022.